BNGO - Bionano Genomics, Inc.
2.95
-0.080 -2.712%
Share volume: 141,688
Last Updated: 04-07-2025
Measuring And Control Equipment/Lab Analytical Instruments:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$3.03
-0.08
-0.03%
Fundamental analysis
25%
Profitability
8%
Dept financing
10%
Liquidity
52%
Performance
40%
Performance
5 Days
-12.20%
1 Month
-20.59%
3 Months
1,197.84%
6 Months
601.05%
1 Year
178.30%
2 Year
-71.08%
Key data
Stock price
$2.95
DAY RANGE
$2.68 - $3.16
52 WEEK RANGE
$0.12 - $6.98
52 WEEK CHANGE
$180.95
DIVIDEND
$0.00
EX-DIVIDEND DATE
01-27-2025
NEXT EARNINGS DATE
05-07-2025
Company detail
CEO: Robert E. Holmlin
Region: US
Website: bionanogenomics.com
Employees: 300
IPO year: 2018
Issue type: Common Stock
Market: XNAS
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing
Region: US
Website: bionanogenomics.com
Employees: 300
IPO year: 2018
Issue type: Common Stock
Market: XNAS
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping. NxClinical offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics.
Recent news
